# A Study of ZT002 Injection With Subjects With Overweight or Obesity

> **NCT07020884** · PHASE2 · COMPLETED · sponsor: **Beijing QL Biopharmaceutical Co.,Ltd** · enrollment: 303 (actual)

## Conditions studied

- Overweight or Obesity

## Interventions

- **DRUG:** ZT002 Injection
- **DRUG:** ZT002 Placebo

## Key facts

- **NCT ID:** NCT07020884
- **Lead sponsor:** Beijing QL Biopharmaceutical Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-14
- **Primary completion:** 2025-05-07
- **Final completion:** 2025-05-29
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07020884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07020884, "A Study of ZT002 Injection With Subjects With Overweight or Obesity". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT07020884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*